Trinity Biotech PLCNASDAQ:TRIBNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE2.8250
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots2.8300/ 12
- Ask / Lots3.5300/ 10
- Open / Previous Close3.0400 / 2.8250
- Day Range
- 52 Week Range
- Volume313,838
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TRIB |
|---|---|---|
| 09:32 ET | 13930 | 3 |
| 09:34 ET | 2262 | 3.0299 |
| 09:36 ET | 700 | 3.02 |
| 09:38 ET | 1825 | 3.02 |
| 09:39 ET | 210 | 2.965 |
| 09:41 ET | 3000 | 2.98 |
| 09:43 ET | 150 | 2.9656 |
| 09:45 ET | 325 | 2.96 |
| 09:48 ET | 250 | 2.967 |
| 09:50 ET | 100 | 2.9687 |
| 09:56 ET | 1230 | 2.965 |
| 09:57 ET | 100 | 2.96 |
| 09:59 ET | 1388 | 2.99 |
| 10:01 ET | 1105 | 2.9925 |
| 10:03 ET | 5093 | 3.05 |
| 10:06 ET | 3498 | 3.066 |
| 10:08 ET | 6400 | 3.085 |
| 10:10 ET | 7917 | 3.1 |
| 10:12 ET | 200 | 3.09 |
| 10:15 ET | 293 | 3.1 |
| 10:17 ET | 5380 | 3.18 |
| 10:19 ET | 2400 | 3.19 |
| 10:21 ET | 3590 | 3.24 |
| 10:26 ET | 960 | 3.24 |
| 10:28 ET | 4241 | 3.255 |
| 10:30 ET | 934 | 3.273 |
| 10:32 ET | 3125 | 3.3 |
| 10:33 ET | 2565 | 3.2899 |
| 10:35 ET | 700 | 3.2628 |
| 10:37 ET | 600 | 3.28 |
| 10:39 ET | 7103 | 3.29 |
| 10:42 ET | 4586 | 3.2 |
| 10:46 ET | 543 | 3.3099 |
| 10:48 ET | 1100 | 3.255 |
| 10:50 ET | 1950 | 3.255 |
| 10:51 ET | 500 | 3.22 |
| 10:53 ET | 600 | 3.24 |
| 11:00 ET | 3020 | 3.26 |
| 11:02 ET | 4000 | 3.31 |
| 11:04 ET | 2168 | 3.2001 |
| 11:08 ET | 1775 | 3.28 |
| 11:09 ET | 800 | 3.25 |
| 11:11 ET | 1143 | 3.3 |
| 11:13 ET | 656 | 3.29 |
| 11:15 ET | 7447 | 3.3 |
| 11:18 ET | 4200 | 3.31 |
| 11:20 ET | 14500 | 3.385 |
| 11:22 ET | 2049 | 3.31 |
| 11:24 ET | 5938 | 3.25 |
| 11:26 ET | 2125 | 3.4599 |
| 11:27 ET | 2899 | 3.3963 |
| 11:29 ET | 8875 | 3.2679 |
| 11:36 ET | 455 | 3.34 |
| 11:38 ET | 788 | 3.35 |
| 11:40 ET | 100 | 3.349 |
| 11:42 ET | 4214 | 3.35 |
| 11:44 ET | 9762 | 3.415 |
| 11:45 ET | 5360 | 3.55 |
| 11:47 ET | 3889 | 3.4 |
| 11:49 ET | 906 | 3.23 |
| 11:56 ET | 1124 | 3.32 |
| 11:58 ET | 18754 | 3.2 |
| 12:02 ET | 11100 | 3.13 |
| 12:05 ET | 754 | 3.19 |
| 12:07 ET | 1000 | 3.19 |
| 12:20 ET | 24522 | 2.77 |
| 12:21 ET | 2782 | 2.81 |
| 12:23 ET | 1600 | 2.9027 |
| 12:25 ET | 696 | 2.98 |
| 12:27 ET | 340 | 2.76 |
| 12:34 ET | 766 | 2.9799 |
| 12:36 ET | 4903 | 2.75 |
| 12:38 ET | 1162 | 2.82 |
| 12:41 ET | 194 | 2.82 |
| 12:50 ET | 117 | 2.9769 |
| 12:52 ET | 500 | 2.905 |
| 12:59 ET | 325 | 2.86 |
| 01:10 ET | 100 | 2.89 |
| 01:19 ET | 500 | 2.88 |
| 01:24 ET | 420 | 2.88 |
| 01:32 ET | 200 | 2.85 |
| 01:46 ET | 200 | 2.88 |
| 01:55 ET | 200 | 2.87 |
| 02:02 ET | 250 | 2.8552 |
| 02:04 ET | 5043 | 2.81 |
| 02:06 ET | 115 | 2.8227 |
| 02:09 ET | 2000 | 2.88 |
| 02:20 ET | 3800 | 2.74 |
| 02:24 ET | 100 | 2.73 |
| 02:26 ET | 2300 | 2.77 |
| 02:29 ET | 6887 | 2.785 |
| 02:31 ET | 2848 | 2.79 |
| 02:33 ET | 865 | 2.7999 |
| 03:12 ET | 925 | 2.7401 |
| 03:14 ET | 908 | 2.7799 |
| 03:20 ET | 100 | 2.78 |
| 03:27 ET | 100 | 2.7672 |
| 03:32 ET | 1500 | 2.77 |
| 03:41 ET | 100 | 2.77 |
| 03:45 ET | 100 | 2.76 |
| 03:48 ET | 100 | 2.7751 |
| 03:52 ET | 600 | 2.7905 |
| 03:56 ET | 1135 | 2.79 |
| 03:57 ET | 100 | 2.79 |
| 03:59 ET | 900 | 2.825 |
Jun 10, 2024
Trinity Biotech Attending 84th Scientific Sessions of the American Diabetes Association, from 9:10AM ET on Monday Jun 10, 2024 by Dow Jones
9:10AM ET on Monday Jun 10, 2024 by Dow Jones
Jun 3, 2024
Trinity Biotech Launches its Continuous Glucose Monitoring Microsite to Showcase its Innovative & Differentiated Technology, from 4:00AM ET on Monday Jun 03, 2024 by Dow Jones
4:00AM ET on Monday Jun 03, 2024 by Dow Jones
May 23, 2024
Trinity Biotech Announces Q1 2024 Financial Results and Reiterates Guidance, from 8:00AM ET on Thursday May 23, 2024 by Dow Jones
8:00AM ET on Thursday May 23, 2024 by Dow Jones*DJ Trinity Biotech 1Q Rev $14.7M >TRIB, from 8:00AM ET on Thursday May 23, 2024 by Dow Jones
8:00AM ET on Thursday May 23, 2024 by Dow Jones
May 21, 2024
Trinity Biotech plc to Announce Q1 2024 Financial Results, from 4:05PM ET on Tuesday May 21, 2024 by Dow Jones
4:05PM ET on Tuesday May 21, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Trinity Biotech PLC | 21.6M | -0.6x | --- |
Retractable Technologies Inc | 34.7M | -4.4x | --- |
Sonendo Inc | 6.6M | -0.2x | --- |
Minerva Surgical Inc | 8.9K | 0.0x | --- |
Dalrada Financial Corp | 15.0M | -0.7x | --- |
SANUWAVE Health Inc | 20.6M | -0.7x | --- |
Company Information
Trinity Biotech PLC is an Ireland-based develops, acquires, manufactures and markets medical diagnostic systems, including both reagents and instrumentation for the clinical laboratory and point-of-care segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. Its segments include the Americas and Rest of World. It is a provider of raw materials to the life sciences and research industries globally. It also operates a licensed reference laboratory that specializes in diagnostics for autoimmune diseases. Its POC brands include Uni-Gold, Recombigen, MarDx, FlexTrans, Premier and Ultra. Its clinical laboratory brands include ImmuBlot, ImmuGlo, ImmuLisa, OTOblot and EZ. The Company manufactures kits for the detection of specialty and esoteric biomarkers of infectious diseases and other associated laboratory products.
Contact Information
- Headquarters
- Ida Business Park Bray, Co Wicklow, IrelandBRAY, Ireland 18
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Aris Kekedjian
- Founder, Executive Director
- Ronan O'caoimh
- Chief Financial Officer, Executive Director, Company Secretary
- John Gillard
- Chief Technology Officer
- Gary Keating
- Chief Accounting Officer
- Simon Dunne
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $27.4M |
|---|---|
Revenue (TTM) | $56.7M |
Shares Outstanding | 1.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.29 |
EPS | $-4.42 |
Book Value | $-15.67 |
P/E Ratio | -0.6x |
Price/Sales (TTM) | 0.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -46.15% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
